We believe that a patient’s OWN stem cells (autologous) have the power to heal. Other stem cell technologies are using umbilical, fetal, embryonic and other allogeneic cells (from other donors or banks), which in and of themselves have theoretical inherent risks for tumor formation, rejection and failure. We also believe that if a stem cell is altered genetically (genetically modified) it may not act as a pluripotential stem cell anymore at all. For this reason, we have started our research with autologous non-modified stem cells.

Sources of autologous stem cells are another concern. Bone marrow, and fat are the most popular. Fat is the easiest, least painful and most plentiful resource.

Cell expansion, we believe is critical, and dose escalation studies will be underway. In our preliminary human work, we obtained significant results with injections of 1 million adipose dervied stem cells. Expansion of pure cells to 30 or 50 million is not an unrealistic goal going forward. And an FDA submission of a phase 1/2 trial of our activated cell line with escalated dosing is currently pending.


Liposuction is used to extract fat from the body in a 20-minute procedure, and the autologous stem cells are isolated and expanded, and kept in our cell bank. A reservoir is placed into the brain, another 20-minute procedure as an outpatient, and later the stem cells are injected via this port into the brain. Booster injections through the implanted port can usually be done every 2-3 months.

Discover The Future

Our company is at the forefront of the biomedical research industry thanks to professionals who have had more than 30 years of medical and research experience.

Contact Us
Go to Top